US FDA Advisory Committee votes in favour of maintaining accelerated approval of Roche’s Tecentriq for PD-L1-positive, metastatic triple-negative breast cancer

Basel, 28 April 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 7 to 2 in favour of maintaining accelerated approval of Tecentriq® (atezolizumab) in combination with chemotherapy (Abraxane®, albumin-bound paclitaxel; nab-paclitaxel) for the treatment of adults with unresectable locally... Read more

Bio-Techne Announces Commercial Release of Novel DNAscope In Situ Hybridization Assays for Chromogenic Detection of DNA Copy Number and Structural Variations

APRIL 27, 2021 Pushing the Spatial Genomics Frontier One Biomolecule at a Time from RNA to DNA MINNEAPOLIS, April 27, 2021 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced the expansion of the Advanced Cell Diagnostics (ACD), a Bio-Techne brand, RNAscope™ technology with release of new DNAscope Assays. The RNAscope technology is an advanced in situ hybridization (ISH)... Read more

Imaging Enhanced: Today´s Raman Microscopy Applications

We’re hosting a half-day virtual symposium in cooperation with Spectroscopy Online that will take place on May 19th at 1 p.m. EDT.  This event will feature scientific talks from researchers in academia and industry. Exciting and resonant topics of presentations will include microplastics, 2D materials, human health, biology, geoscience and electrochemistry. The theoretical foundations of... Read more

The Carlyle Group to acquire rapidly growing life sciences tools company Unchained Labs

April 26, 2021 – Pleasanton, CA – Global investment firm The Carlyle Group (NASDAQ:CG) today announced that it has agreed to acquire the rapidly growing life sciences tools company Unchained Labs for $435 million, in partnership with its management team, from Novo Holdings A/S, Canaan Partners and TPG Biotech. The transaction is subject to regulatory... Read more

Danaher Announces Renowned Scientists To Join New Scientific Advisory Board

DIVERSE SCIENTIFIC EXPERTISE AND PROPRIETARY INSIGHTS WILL SUPPORT COMPANY GROWTH AND IMPACT WASHINGTON, April 26, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher”), the global science and technology company, announced today the formation of a Scientific Advisory Board (“Board”) to support its innovation and investment strategy. The Board will help the company protect and grow existing... Read more

Pacific Biosciences Launches New HiFi Sequencing Workflow to Further Improve HiFi’s Industry Leading Accuracy

HiFi Sequencing and Software v10.1 Release on the Sequel II and IIe Systems Increases Scalability, Improves Usability, and Unlocks Additional Sample Types to Extend the Value of HiFi Reads MENLO PARK, Calif., April 26, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB), a global leader offering a comprehensive view of genomes, transcriptomes, and epigenomes,... Read more

Pacific Biosciences Launches New HiFi Sequencing Workflow to Further Improve HiFi’s Industry Leading Accuracy

HiFi Sequencing and Software v10.1 Release on the Sequel II and IIe Systems Increases Scalability, Improves Usability, and Unlocks Additional Sample Types to Extend the Value of HiFi Reads MENLO PARK, Calif., April 26, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB), a global leader offering a comprehensive view of genomes, transcriptomes, and epigenomes,... Read more